[A TRADUIRE] Une aide publique de 6 M€ pour trois projets labellisés par Lyonbiopôle
KEY POINTS
Lyon, a leading city in life sciences
BIOPARC LYON, fully dedicated to biotech companies
A 3.4 ha site
40,000 square meters hosting offices and laboratories, a business incubator, technical rooms, a residential complex, support services...
€6 MILLION
IN PUBLIC FUNDING
Three R&D projects accredited by the Lyonbiopôle cluster have been selected for funding by the French government's 8th Fonds Unique Interministeriel call for R&D proposals.
A total of €6 million in public grants-in-aid has been awarded by the French State, European Regional Development Fund, the Rhône-Alpes Regional Council, Greater Lyon and Grenoble Alpes Metropole.
EXPAND ID, NATHEB and PATVAX are all business-led R&D projects dedicated to combating infectious disease.
The EXPAND ID project is seeking to explore intradermal vaccination applications, following the success of the first intradermal influenza vaccine. The project is led by BD in Grenoble, with support from Sanofi Pasteur and INSERM unit U851 in Lyon.
NATHEB (novel approaches to treatment of chronic hepatitis B infections) is a 100% Lyon-based project led by the company EDELRIS. The INSERM national research institute and the life science companies POXEL and TRANSGENE are project partners.
The PATVAX project is seeking to develop innovative devices for measuring biological interactions in heterogeneous milieus, for use in the in-line monitoring of industrial biomanufacturing processes. The project is led by Sanofi Pasteur in Lyon and includes other Lyon-based partners (MERIAL, SmartINST and the ENS Physics Laboratory) and Grenoble-based organizations (CEA LETI and CYBERSTAR).
For more information:
www.lyonbiopole.org
